Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders

Imported from official source

MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.

This version

Version
1 of 1
Recorded
October 30, 2026 16:00
Change
Initial
Content hash
5832cf76b9389b857dadde3a1cd55a29
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.